Gender differences in protection from EAE induced by oral tolerance with a peptide analogue of MBP‐Ac1–11
暂无分享,去创建一个
[1] J. Correale,et al. Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects. , 1998, Journal of immunology.
[2] M. Hutchinson,et al. Rate of Pregnancy-Related Relapse in Multiple Sclerosis , 1998 .
[3] G. Adamus,et al. Gonadal hormones influence the immune response to PLP 139–151 and the clinical course of relapsing experimental autoimmmune encephalomyelitis , 1998, Journal of Neuroimmunology.
[4] H. Weiner. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. , 1997, Immunology today.
[5] R. Voskuhl,et al. Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. , 1997, Journal of immunology.
[6] L. Weiner,et al. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. , 1997, Journal of immunology.
[7] C. Whitacre,et al. Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. , 1996, Journal of immunology.
[8] A. Vandenbark,et al. Male SJL mice do not relapse after induction of EAE with PLP 139–151 , 1996, Journal of neuroscience research.
[9] A. MacKenzie-Graham,et al. Gender differences in autoimmune demyelination in the mouse: Implications for multiple sclerosis , 1996, Annals of neurology.
[10] C. Whitacre,et al. Oral Tolerance in Experimental Autoimmune Encephalomyelitis , 1996, Annals of the New York Academy of Sciences.
[11] D. Wraith,et al. Mucosal Tolerance in a Murine Model of Experimental Autoimmune Encephalomyelitis a , 1996, Annals of the New York Academy of Sciences.
[12] H. Braley‐Mullen,et al. Suppression of murine experimental autoimmune thyroiditis by oral administration of porcine thyroglobulin. , 1995, Cellular immunology.
[13] Laurie H Glimcher,et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy , 1995, Cell.
[14] N. Olsen,et al. Immunochemical and flow cytometric analysis of androgen receptor expression in thymocytes , 1995, Molecular and Cellular Endocrinology.
[15] H. McFarland,et al. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. , 1995, Critical reviews in clinical laboratory sciences.
[16] E. Shevach,et al. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. , 1994 .
[17] T. Olsson,et al. Estrogen induces a potent suppression of experimental autoimmune encephalomyelities and collagen-induced arthritis in mice , 1994, Journal of Neuroimmunology.
[18] C. Raine. The Dale E. McFarlin memorial lecture: The immunology of the multiple sclerosis lesion , 1994, Annals of neurology.
[19] D. Wraith,et al. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. , 1993, International immunology.
[20] H. Weiner,et al. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. , 1993, Science.
[21] C. Janeway,et al. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma , 1993, The Journal of experimental medicine.
[22] P. Nieuwenhuis,et al. Suppression of acute experimental allergic encephalomyelitis by the synthetic sex hormone 17-alpha-ethinylestradiol: an immunological study in the Lewis rat. , 1993, International archives of allergy and immunology.
[23] P. Duquette. The Increased Susceptibility of Women to Multiple Sclerosis , 1992, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[24] H. Weiner,et al. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain , 1992, The Journal of experimental medicine.
[25] J. Merrill,et al. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[26] M. Sporn,et al. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[27] C. Whitacre,et al. Sex and strain differences in the circadian rhythm fluctuation of endocrine and immune function in the rat: implications for rodent models of autoimmune disease , 1991, Journal of Neuroimmunology.
[28] H. Weiner,et al. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. , 1991 .
[29] C. Orosz,et al. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. , 1991, Journal of immunology.
[30] D. Bourdette,et al. Myelin basic protein specific T cell lines and clones derived from the CNS of rats with EAE only recognize encephalitogenic epitopes , 1991, Journal of neuroscience research.
[31] H. Weiner,et al. Antigen-driven bystander suppression after oral administration of antigens , 1991, The Journal of experimental medicine.
[32] R. Rudick,et al. The clinical course of multiple sclerosis during pregnancy and the puerperium. , 1990, Archives of neurology.
[33] H. Weiner,et al. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. , 1990, Journal of immunology.
[34] C. Whitacre,et al. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. , 1988, Cellular immunology.
[35] B. Beutler,et al. Tumor necrosis, cachexia, shock, and inflammation: a common mediator. , 1988, Annual review of biochemistry.
[36] H. Weiner,et al. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments , 1987, Journal of Neuroimmunology.
[37] Lawrence Steinman,et al. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis , 1986, Nature.
[38] G. Thorbecke,et al. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[39] N. Staines,et al. Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. , 1986, Clinical and experimental immunology.
[40] V. Rumjanek,et al. Pregnancy and the susceptibility of Lewis rats to experimental allergic encephalomyelitis , 1985, Journal of the Neurological Sciences.
[41] O. Abramsky,et al. Suppressive Effect of Pregnancy on the Development of Experimental Allergic Encephalomyelitis in Rabbits , 1984, American journal of reproductive immunology : AJRI : official journal of the American Society for the Immunology of Reproduction and the International Coordination Committee for Immunology of Reproduction.
[42] P. Y. Paterson. Experimental allergic encephalomyelitis and autoimmune disease. , 1966, Advances in immunology.